These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 4298956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Fluphenazine enanthate, delayed-action neuroleptic dru utilizable in outpatients treatment of chronic psychosis].
    Lambert PA, Midenet M, Marcou G, Bouchardy M.
    J Med Lyon; 1967 Mar 05; 48(116):351-5. PubMed ID: 5614941
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR, Lavallee B.
    Dis Nerv Syst; 1969 Feb 05; 30(2):98-102. PubMed ID: 5774574
    [No Abstract] [Full Text] [Related]

  • 5. [Experience with a new depot neuroleptic].
    Christiani K.
    Med Klin; 1969 Sep 26; 64(39):1761-2. PubMed ID: 5346114
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD, Neumann J.
    Z Arztl Fortbild (Jena); 1984 Sep 26; 78(20):853-6. PubMed ID: 6523910
    [No Abstract] [Full Text] [Related]

  • 7. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC, Sweet RA, Chengappa KN, Reddy RR, Jeste DV.
    Int J Geriatr Psychiatry; 2002 Nov 26; 17(11):1012-7. PubMed ID: 12404650
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical experience with fluphenazine decanoate in psychoses].
    Náhunek K, Rodová A, Svestka J.
    Act Nerv Super (Praha); 1970 Jan 12; 12(1):47-9. PubMed ID: 5460564
    [No Abstract] [Full Text] [Related]

  • 15. [Experience in the management of chronic psychoses using fluphenazine-oenanthate].
    Eichstetter F.
    Nervenarzt; 1968 Jun 12; 39(6):282-3. PubMed ID: 5712435
    [No Abstract] [Full Text] [Related]

  • 16. [Advantages and indications of Moditen-Retard].
    Vallade L.
    Encephale; 1970 Jun 12; ():Suppl:10-3. PubMed ID: 5458707
    [No Abstract] [Full Text] [Related]

  • 17. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 Jun 12; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 18. [Complementary neurolepsy].
    Petrilowitsch N, Herzog R.
    Psychiatr Neurol (Basel); 1966 Jun 12; 151(4):195-207. PubMed ID: 5925592
    [No Abstract] [Full Text] [Related]

  • 19. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D, Péron-Magnan P.
    Rev Prat; 1972 Apr 21; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract] [Full Text] [Related]

  • 20. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT, Hoerdt HP.
    Ann Med Psychol (Paris); 1972 Feb 21; 1(2):277-83. PubMed ID: 5051257
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.